240 related articles for article (PubMed ID: 18292932)
1. Downregulation of matrix metalloproteinase-2 (MMP-2) utilizing adenovirus-mediated transfer of small interfering RNA (siRNA) in a novel spinal metastatic melanoma model.
Tsung AJ; Kargiotis O; Chetty C; Lakka SS; Gujrati M; Spomar DG; Dinh DH; Rao JS
Int J Oncol; 2008 Mar; 32(3):557-64. PubMed ID: 18292932
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice.
Chetty C; Bhoopathi P; Joseph P; Chittivelu S; Rao JS; Lakka S
Mol Cancer Ther; 2006 Sep; 5(9):2289-99. PubMed ID: 16985063
[TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitor of metalloproteinase 3 suppresses tumor angiogenesis in matrix metalloproteinase 2-down-regulated lung cancer.
Chetty C; Lakka SS; Bhoopathi P; Kunigal S; Geiss R; Rao JS
Cancer Res; 2008 Jun; 68(12):4736-45. PubMed ID: 18559520
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma.
Kargiotis O; Chetty C; Gondi CS; Tsung AJ; Dinh DH; Gujrati M; Lakka SS; Kyritsis AP; Rao JS
Oncogene; 2008 Aug; 27(35):4830-40. PubMed ID: 18438431
[TBL] [Abstract][Full Text] [Related]
5. Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo.
Zhao F; Zhang Q; Kang C; Cui X; Wang T; Xu P; Zhou X; Liu J; Song X
Med Oncol; 2010 Sep; 27(3):774-84. PubMed ID: 19680827
[TBL] [Abstract][Full Text] [Related]
6. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
[TBL] [Abstract][Full Text] [Related]
7. Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer.
Wang X; Zhang K; Sun L; Liu J; Lu H
Med Oncol; 2011 Dec; 28 Suppl 1():S413-22. PubMed ID: 21053100
[TBL] [Abstract][Full Text] [Related]
8. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Rao JS; Gondi C; Chetty C; Chittivelu S; Joseph PA; Lakka SS
Mol Cancer Ther; 2005 Sep; 4(9):1399-408. PubMed ID: 16170032
[TBL] [Abstract][Full Text] [Related]
10. Effects of RNAi-mediated matrix metalloproteinase-2 gene silencing on the invasiveness and adhesion of esophageal carcinoma cells, KYSE150.
Shen YG; Xu YJ; Shi ZL; Han HL; Sun DQ; Zhang X
Dig Dis Sci; 2012 Jan; 57(1):32-7. PubMed ID: 21879284
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of angiopoietin-2 suppresses metastasis in human pancreatic carcinoma by reduced matrix metalloproteinase-2.
Zhang ZX; Zhou J; Zhang Y; Zhu DM; Li DC; Zhao H
Mol Biotechnol; 2013 Mar; 53(3):336-44. PubMed ID: 22457202
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
13. MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway.
Rao JS; Bhoopathi P; Chetty C; Gujrati M; Lakka SS
Cancer Res; 2007 May; 67(10):4956-64. PubMed ID: 17510426
[TBL] [Abstract][Full Text] [Related]
14. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
15. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
16. Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2).
Malik MT; Kakar SS
Mol Cancer; 2006 Nov; 5():61. PubMed ID: 17096843
[TBL] [Abstract][Full Text] [Related]
17. MMP-2 siRNA induced Fas/CD95-mediated extrinsic II apoptotic pathway in the A549 lung adenocarcinoma cell line.
Chetty C; Bhoopathi P; Lakka SS; Rao JS
Oncogene; 2007 Dec; 26(55):7675-83. PubMed ID: 17599056
[TBL] [Abstract][Full Text] [Related]
18. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
19. Black tea polyphenol (theaflavin) downregulates MMP-2 in human melanoma cell line A375 by involving multiple regulatory molecules.
Sil H; Sen T; Moulik S; Chatterjee A
J Environ Pathol Toxicol Oncol; 2010; 29(1):55-68. PubMed ID: 20528747
[TBL] [Abstract][Full Text] [Related]
20. Wild-type p53 gene transfer inhibits invasion and reduces matrix metalloproteinase-2 levels in p53-mutated human melanoma cells.
Toschi E; Rota R; Antonini A; Melillo G; Capogrossi MC
J Invest Dermatol; 2000 Jun; 114(6):1188-94. PubMed ID: 10844565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
